Calliditas Therapeutics AB OverviewCalliditas Therapeutics AB Other Income Expense Net
Other Income/Expense Net for CALT.
Quarterly Other Income/Expense
-$8.46M
↓ 287.54% YoY
As of Jun 30, 2024
Annual Other Income/Expense (TTM)
-$100.14M
↓ 50.77% YoY
Trailing 12 months ending Jun 30, 2024